The transformation of the normal prostate histoarchitecture, as happens in the case of benign pathology (prostatic hypertrophy or prostatitis) and also in the case of prostate cancer, causes an increase in blood levels of the PSA which must therefore be considered a marker of prostate disease [2]. Here, KLK3 is linked to prostate carcinoma.